TERADYNE, INC. Proceeds from Sale and Maturity of Marketable Securities
TERADYNE, INC. (TER) reported Proceeds from Sale and Maturity of Marketable Securities of $29.61 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2026-07-31
- TERADYNE, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2026-06-28 was $2.29M, a 19.87% decline year-over-year.
- TERADYNE, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2026-03-29 was $27.33M, a 385.14% increase year-over-year.
- TERADYNE, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2025-12-31 was $167.00K, a 61.61% decline year-over-year.
- TERADYNE, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2025-09-28 was $685.00K, a 70.36% decline year-over-year.
- TERADYNE, INC. proceeds from sale and maturity of marketable securities for fiscal 2025 was $9.34M, a 61.14% decline from fiscal 2024.
- TERADYNE, INC. proceeds from sale and maturity of marketable securities for fiscal 2024 was $24.04M, a 60.86% decline from fiscal 2023.
- TERADYNE, INC. proceeds from sale and maturity of marketable securities for fiscal 2023 was $61.40M, a 77.09% decline from fiscal 2022.
- TERADYNE, INC. proceeds from sale and maturity of marketable securities for fiscal 2022 was $268.06M, a 0.60% increase from fiscal 2021.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 9 month as first filed | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|---|
| 2026-06-28 | $2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $29.61M 10-Q · filed 2026-07-31 | $29.78M derived: sum of 3 quarters · filed 2026-07-31 | $30.47M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2026-03-29 | $27.33M 10-Q · filed 2026-05-01 | $27.50M derived: sum of 2 quarters · filed 2026-05-01 | $28.18M derived: sum of 3 quarters · filed 2026-05-01 | $31.03M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-12-31 | $167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $852.00K derived: sum of 2 quarters · filed 2026-02-19 | $3.71M derived: sum of 3 quarters · filed 2026-07-31 | $9.34M 10-K · filed 2026-02-19 | |
| 2025-09-28 | $685.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $3.54M derived: sum of 2 quarters · filed 2026-07-31 | $9.17M 10-Q · filed 2025-10-30 | $9.61M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-06-29 | $2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $8.49M 10-Q · filed 2026-07-31 | $8.92M derived: sum of 3 quarters · filed 2026-07-31 | $11.23M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-03-30 | $5.63M 10-Q · filed 2026-05-01 | $6.07M derived: sum of 2 quarters · filed 2026-05-01 | $8.38M derived: sum of 3 quarters · filed 2026-05-01 | $8.93M derived: sum of 4 quarters · filed 2026-05-01 | |
| 2024-12-31 | $435.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.75M derived: sum of 2 quarters · filed 2026-02-19 | $3.30M derived: sum of 3 quarters · filed 2026-02-19 | $24.04M 10-K · filed 2026-02-19 | |
| 2024-09-29 | $2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $2.87M derived: sum of 2 quarters · filed 2025-10-30 | $23.60M 10-Q · filed 2025-10-30 | $48.04M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2024-06-30 | $555.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $21.29M 10-Q · filed 2025-08-01 | $45.73M derived: sum of 3 quarters · filed 2026-02-19 | $47.11M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2024-03-31 | $20.73M 10-Q · filed 2025-05-02 | $45.17M derived: sum of 2 quarters · filed 2026-02-19 | $46.56M derived: sum of 3 quarters · filed 2026-02-19 | $74.21M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2023-12-31 | $24.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $25.82M derived: sum of 2 quarters · filed 2026-02-19 | $53.47M derived: sum of 3 quarters · filed 2026-02-19 | $61.40M 10-K · filed 2026-02-19 | |
| 2023-10-01 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $29.03M derived: sum of 2 quarters · filed 2024-11-01 | $36.96M 10-Q · filed 2024-11-01 | $45.82M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2023-07-02 | $27.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $35.58M 10-Q · filed 2024-08-02 | $44.44M derived: sum of 3 quarters · filed 2025-02-20 | $159.99M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2023-04-02 | $7.93M 10-Q · filed 2024-05-03 | $16.79M derived: sum of 2 quarters · filed 2025-02-20 | $132.34M derived: sum of 3 quarters · filed 2025-02-20 | $245.41M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2022-12-31 | $8.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $124.42M derived: sum of 2 quarters · filed 2025-02-20 | $237.48M derived: sum of 3 quarters · filed 2025-02-20 | $268.06M 10-K · filed 2025-02-20 | |
| 2022-10-02 | $115.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $228.62M derived: sum of 2 quarters · filed 2023-11-03 | $259.20M 10-Q · filed 2023-11-03 | $182.09M 10-Q · filed 2022-11-04 | -$45.61M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-07-03 | $113.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $143.64M 10-Q · filed 2023-08-04 | -$161.17M derived: sum of 3 quarters · filed 2024-02-22 | $294.00M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-04-03 | $30.58M 10-Q · filed 2023-05-05 | -$274.23M derived: sum of 2 quarters · filed 2024-02-22 | $180.94M derived: sum of 3 quarters · filed 2024-02-22 | $235.75M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2021-12-31 | -$304.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $150.35M derived: sum of 2 quarters · filed 2024-02-22 | $205.17M derived: sum of 3 quarters · filed 2024-02-22 | $266.47M 10-K · filed 2024-02-22 | |
| 2021-10-03 | $455.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $509.98M derived: sum of 2 quarters · filed 2022-11-04 | $571.28M 10-Q · filed 2022-11-04 | ||
| 2021-07-04 | $54.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $116.11M 10-Q · filed 2022-08-05 | |||
| 2021-04-04 | $61.29M 10-Q · filed 2022-05-06 | ||||
| 2020-12-31 | $35.01M 10-K · filed 2023-02-22 | ||||
| 2019-12-31 | $105.59M 10-K · filed 2022-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veralto Corp (VLTO) | United States | $23.619B | 22.32 |
| ITRON, INC. (ITRI) | United States | $4.008B | 13.83 |
| AEHR TEST SYSTEMS (AEHR) | United States | $3.176B | -420.65 |
| COHU INC (COHU) | United States | $3.015B | -82.78 |
| ALLIENT INC (ALNT) | United States | $1.913B | 61.10 |
| FREQUENCY ELECTRONICS INC (FEIM) | United States | $0.952B | 236.51 |
| TRANSCAT INC (TRNS) | United States | $0.805B | 250.33 |
| INTEST CORP (INTT) | United States | $0.146B | 291.94 |
| ScanTech AI Systems Inc. (STAI) | United States | $0.069B | -2.69 |
| DATA I/O CORP (DAIO) | United States | $0.030B | -4.65 |